Efforts Continue to Repeal Onerous R&D Amortization Rules

The Tax Relief for American Families and Workers Act of 2024 or HB 7204 was introduced that would, among other things, repeal current rules and allow a business to deduct of R&D costs in the tax year that they occur and thereby incentivize long-term investments in innovation. Such repeal has been a top policy priority…

Read More

MichBio Hosts Inaugural Life Sciences Legislative Academy

MichBio hosted a unique and exclusive event for legislators, a Michigan Life Sciences Legislative Academy, wherein bio-industry leaders gathered to educate elected officials about the life sciences ecosystem in Michigan, its economics, and unique needs of the industry, as well as pressing issues related to serving patients, developing treatments, and improving the quality of life…

Read More

State R&D Tax Credit to be Reestablished

A package of bills that would reestablish a state research & development R&D) tax credit in Michigan – HBs 4368, 5099, 5100, 5101 and 5102 – passed by the Michigan Senate in bipartisan fashion 22-13 on March 19, 2024. As proposed, taxpayers and authorized businesses with 250 or more employees could claim up to $2.0…

Read More

A Tribute to a Giant of Michigan’s Biosciences Community

James (Jim) Herbert, who passed away recently, was a founding father of Michigan’s biotechnology ecosystem. He brought to his work, and to his life, a passion, a vision and a perseverance rooted in his belief that biotechnology was the way of the future. In so doing, Herbert co-founded and built Neogen, a pioneering multi-national food…

Read More

TrialAssure Launches Anonymize 3.0 Technology for an Improved Data and Document Anonymization User Experience in Pharma and Beyond

TrialAssure, a leading pharmaceutical technology provider advancing clinical trial disclosure, data sharing, and transparency, announced that its flagship product TrialAssure ANONYMIZE® 3.0 is now available. ANONYMIZE allows users across the pharmaceutical industry the ability to perform data, document, and image anonymization and redaction using machine learning (ML), natural language processing (NLP), and artificial intelligence (AI)…

Read More

90,000 sq. ft. Expansion of Grand River Aseptic Manufacturing’s Finishing and Warehouse Center is Complete

 Grand River Aseptic Manufacturing (“GRAM”), a leading sterile injectable contract manufacturer of biologics, small molecules, and vaccines, announces the completion of its finishing and warehouse center expansion. The expansion added 90,000 sq. ft. to the existing 110,000 sq. ft., totaling 200,000 sq. ft. of sophisticated inspection, packaging, testing, and warehouse capabilities. Grand River Aseptic Manufacturing…

Read More

Cayman Chemical Introduces LipidLaunch™, Expands Portfolio of Lipid Nanoparticle Research Tools to Support Advances in RNA Therapies

ANN ARBOR, MI, FEBRUARY 22, 2024 – Cayman Chemical, a leading supplier of research tools for lipid nanoparticles (LNPs), announced today the introduction of LipidLaunch™ research-ready LNPs and reagent kits. The LipidLaunch™ product line is the latest addition to the company’s portfolio of LNP research tools and reflects the company’s legacy of providing high-quality lipids…

Read More

Reflections on 2023

As 2023 ends, we’ve been reflecting on the impact our team made on Michigan’s life sciences industry. While there were certainly challenges along the way, we’re proud of the work done here at MichBio and hope you’ve noticed our efforts to convene, connect, inform, and advocate for the statewide life sciences cluster. Some reflections on…

Read More

Rare Disease Advisory Council

Legislation (HB 4167) to establish a Rare Disease Advisory Council (RDAC) in Michigan were progressing nicely through the summer following overwhelming bipartisan passage by the full House. A RDAC would empower rare disease patients as partners in helping to shape policy development relevant to the unmet needs, common struggles, and concerns on equitable, quality, and…

Read More

Regulation of Dogs and Cats in Research

SB 148 and SB 149, sponsored by Sen. Polehanki and Sen. Hertel, respectively, sought to regulate the use/disposition of animals in research including mandatory reporting on numbers of animals owned, used, and released by research facilities, mandatory requirement for adoption of research animals post-use, and other restrictions and penalties. The legislation arose after an outcry…

Read More